Correlation Between Biodexa Pharmaceticals and Neurosense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Neurosense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Neurosense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Neurosense Therapeutics, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Neurosense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Neurosense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Neurosense Therapeutics.

Diversification Opportunities for Biodexa Pharmaceticals and Neurosense Therapeutics

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Biodexa and Neurosense is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Neurosense Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurosense Therapeutics and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Neurosense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurosense Therapeutics has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Neurosense Therapeutics go up and down completely randomly.

Pair Corralation between Biodexa Pharmaceticals and Neurosense Therapeutics

Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to under-perform the Neurosense Therapeutics. In addition to that, Biodexa Pharmaceticals is 1.75 times more volatile than Neurosense Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Neurosense Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest  169.00  in Neurosense Therapeutics on August 23, 2024 and sell it today you would lose (77.00) from holding Neurosense Therapeutics or give up 45.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biodexa Pharmaceticals  vs.  Neurosense Therapeutics

 Performance 
       Timeline  
Biodexa Pharmaceticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biodexa Pharmaceticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Neurosense Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Neurosense Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Neurosense Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Biodexa Pharmaceticals and Neurosense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biodexa Pharmaceticals and Neurosense Therapeutics

The main advantage of trading using opposite Biodexa Pharmaceticals and Neurosense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Neurosense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurosense Therapeutics will offset losses from the drop in Neurosense Therapeutics' long position.
The idea behind Biodexa Pharmaceticals and Neurosense Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences